October 15, 2018

Drug Industry Tries To Preempt Trump On Prices

The drug industry's main lobby on Monday moved to head off a Trump administration push on pricing transparency, saying member companies will begin using television ads to direct consumers to information about the cost of medicines.

The move by PhRMA, which takes effect April 15, attempts an end run around the administration's anticipated announcement this week requiring drug companies to include the list price of a drug in advertisements and drew a swift rebuke from HHS Secretary Alex Azar.

"We believe just including list prices is not sufficient and would be misleading for several reasons," said PhRMA CEO Stephen Ubl on a press call Monday morning. List prices are not a good indication of what patients pay since consumers' various insurance benefits will determine their out-of-pocket costs, Ubl said. They also don't include negotiated discounts with pharmacy benefits manag

Elizabeth Warren Hits Back At Trump, Releases Dna Test 'Strongly' Supporting Native American Ancestry

Sen. Elizabeth Warren released the results of a DNA test on Monday that "strongly support" her claims of Native American ancestry, hitting back at President Donald Trump for mocking her and showing her seriousness about a 2020 presidential run.

The DNA test, conducted by Stanford University professor Carlos Bustamante, showed Warren's likely Native American ancestry dates back six to 10 generations.

The release of the results were part of a rollout from Warren's campaign showcasing her heritage while offering evidence that she did not benefit professionally from it. She was hired as an educator, Warren argued, because "she was an award-winning legal scholar and professor."

The rollout, which came with a slick video showing Warren talking about her family with her older brothers, provided a glimp

Lawmakers Clamor For Piece Of Trump Action On House Intel

Dozens of Republican and Democratic lawmakers are clamoring to join the House Intelligence Committee next year — for a chance to be part of a panel at the vanguard of the partisan brawl over Russian interference in the 2016 election.

The interest has veterans of the committee worried that a new class of lawmakers will reinforce the partisan impulses that drove the committee toward dysfunction the past two years. The politicization of the once sober, above-the-fray panel has undermined what some lawmakers and national security officials say has been a decades-long partnership with the intelligence community.

"It has to revert back to the way that it was, sort of like the sleepy little classified committee that nobody ever hears about," said Rep. Tom Rooney (R-Fla.), who joined the House Intelligence Committee in 2011 and is retiring from Congress in January. If the committee remains politicized, "it will be crippled," Rooney said, and "this country will suffer."

Republican and Democratic leaders have been compiling list

October 14, 2018

Rubio: No &Lsquo;Business As Usual&Rsquo; With Saudi Arabia

Sen. Marco Rubio said Sunday the U.S. should not continue with "business as usual" in response to Saudi Arabia following the disappearance of Saudi journalist Jamal Khashoggi.

Rubio, a member of the Senate Foreign Relations Committee, added he did not think Treasury Secretary Steven Mnuchin should attend an upcoming economic summit in Saudi Arabia.

"I don't think he should go," the Florida Republican said on CNN's "State of the Union" on Sunday. "I don't think any of our government officials should be going and pretending it's business as usual until we know exactly what's happened here."

Khashoggi, a Washington Post journalist, has not been seen since entering a Saudi consulate in Turkey earlier this month. Turkey claims Khashoggi was murdered there.

Rubio told host Jake Tapper the United States' response to Khashoggi's disappearance should be strong, and "not just symbolic."

"No matter how important they might be to our Iranian strategy, our ability to be a voice f

How The Liberal Wish List Could Bite Democrats

A Trump-inspired resurgence on the left has even many centrist Democrats embracing an outspokenly liberal wish list as their party hopes to capture one or both chambers of Congress in November.

Just don't count on any of it happening soon.

Even symbolic votes on the growing roster of progressive expectations could create political headaches for Democrats seeking the White House in 2020. That means Medicare for all, debt-free college and a $15 minimum wage will remain more the subject of liberal aspirations than a real shift in the nation's policies.

President Donald Trump is already trying to tar progressive ideas as ballot-box poison, denouncing single-payer health care as Venezuela-style "socialism" (never mind that he endorsed it in 2000) and saying Democrats who want to abolish Immigration and Customs